Zuan-Fu Lim, a cancer cell biology graduate student in Patrick Ma’s lab at the WVU Cancer Institute, has received an American Association of Immunologists Young Investigator Award for his first place oral presentation at the 21st annual meeting of the Translational Research Cancer Centers Consortium at Seven Springs, PA.
Lung cancer cells can adopt various mechanisms of resistance to precision therapy. Lim’s research focused specifically on non-small cell lung cancers (NSCLCs) characterized by chromosomal abnormalities in the ALK gene and found that precision therapy targeting the ALK gene may not be effective because molecular drug resistance can emerge in a non-genetic fashion.
Pictured: David Klinke, PhD, of the WVU Cancer Institute congratulates Zuan-Fu Lim, a cancer cell biology graduate student, for winning an American Association of Immunologists Young Investigator Award.
MORGANTOWN, W.Va. – Lori Hazlehurst, Ph.D., Professor (WVU School of Pharmacy - Pharmaceutical Sciences and Co-Leader of the WVU Cancer Institute Research Program the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, has been named as the Associate Director for Basic Research at the WVU Cancer Institute. In this role, she will work closely with Dr. Richard Goldberg, Institute Director, and the leadership team of the WVU Cancer Institute to implement strategic goals to increase the impact of basic and translational cancer research at WVU. The primary strategy is to increase the number of NIH funded investigators focused on cancer research at WVU